BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10688071)

  • 1. Intravesical therapy for bladder cancer.
    Kamat AM; Lamm DL
    Urology; 2000 Feb; 55(2):161-8. PubMed ID: 10688071
    [No Abstract]   [Full Text] [Related]  

  • 2. Current and new strategies in immunotherapy for superficial bladder cancer.
    Perabo FG; Müller SC
    Urology; 2004 Sep; 64(3):409-21. PubMed ID: 15351555
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravesical therapy for superficial bladder cancer.
    Baselli EC; Greenberg RE
    Oncology (Williston Park); 2000 May; 14(5):719-29; discussion 729-31, 734, 737. PubMed ID: 10853462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.
    Pham HT; Soloway MS
    Semin Urol Oncol; 1997 Aug; 15(3):147-53. PubMed ID: 9394909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical interferon alfa in the treatment of superficial bladder cancer.
    Williams RD
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):10-3. PubMed ID: 3057641
    [No Abstract]   [Full Text] [Related]  

  • 6. [BCG therapy. Its role in the treatment of tumors of the bladder].
    Patard JJ; Chopin DK; Abbou CC
    Ann Urol (Paris); 1995; 29(5):292-3. PubMed ID: 8638911
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravesical therapy for superficial bladder cancer.
    Malkowicz SB
    Semin Urol Oncol; 2000 Nov; 18(4):280-8. PubMed ID: 11101091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical chemotherapy versus immunotherapy for superficial bladder cancer.
    Huben RP
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):17-22. PubMed ID: 8727806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of superficial transitional cell carcinoma of the bladder.
    Fleischmann J; Goldberg G
    Semin Urol; 1993 Nov; 11(4):193-204. PubMed ID: 8290825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When does superficial bladder cancer resist intravesical therapy?
    Vögeli T; Ackermann R
    Semin Urol; 1990 Nov; 8(4):248-53. PubMed ID: 2284531
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypersensitivity pneumonitis as a complication of intravesical BCG therapy for bladder cancer.
    Carrasco Hernández L; Castaño Núñez ÁL; Rodríguez Portal JA
    Arch Bronconeumol; 2016 Aug; 52(8):445-6. PubMed ID: 26920491
    [No Abstract]   [Full Text] [Related]  

  • 12. Strategies to enhance the efficacy of intravescical therapy for non-muscle invasive bladder cancer.
    Smaldone MC; Gayed BA; Tomaszewski JJ; Gingrich JR
    Minerva Urol Nefrol; 2009 Jun; 61(2):71-89. PubMed ID: 19451890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravesical therapy for bladder cancer.
    Soloway MS
    J Urol; 1994 Aug; 152(2 Pt 1):379-81. PubMed ID: 8015075
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravesical therapy in the management of superficial transitional cell carcinoma of the bladder: the experience of the EORTC GU Group.
    Newling D
    Br J Cancer; 1990 Apr; 61(4):497-9. PubMed ID: 2184878
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term results of intravesical bacillus Calmette-Guérin therapy for stage T1 superficial bladder cancer.
    Droller MJ
    J Urol; 2001 Feb; 165(2):701-2. PubMed ID: 11233047
    [No Abstract]   [Full Text] [Related]  

  • 16. Hazardous Drugs in the Urology Workplace: Focus on Intravesical Medications.
    Hensley D
    Urol Nurs; 2016; 36(4):183-9. PubMed ID: 29240329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleural effusion after intravesical administration of bacillus Calmette-Guérin.
    Roca Noval A; Cisneros C; García-Pérez FJ; Domingo D
    Arch Bronconeumol; 2017 Dec; 53(12):694-695. PubMed ID: 28476221
    [No Abstract]   [Full Text] [Related]  

  • 18. Complications of intravesical therapy for urothelial cancer of the bladder.
    Koya MP; Simon MA; Soloway MS
    J Urol; 2006 Jun; 175(6):2004-10. PubMed ID: 16697786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pure squamous cell carcinoma after intravesical BCG treatment. A case report.
    Yurdakul T; Avunduk MC; Piskin MM
    Urol Int; 2005; 74(3):283-5. PubMed ID: 15812221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravesical therapy: does it affect the natural history of superficial bladder cancer?
    Lamm DL; Griffith JG
    Semin Urol; 1992 Feb; 10(1):39-44. PubMed ID: 1565903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.